POLIVY 140 MG PD. FOR INF. VIAL

POLIVY in combination with bendamustine and a rituximab product is indicated for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) not otherwise specified after at least 2 prior therapies.